These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9972140)

  • 1. How do tetracyclines work?
    Ryan ME; Ashley RA
    Adv Dent Res; 1998 Nov; 12(2):149-51. PubMed ID: 9972140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.
    Lokeshwar BL; Houston-Clark HL; Selzer MG; Block NL; Golub LM
    Adv Dent Res; 1998 Nov; 12(2):97-102. PubMed ID: 9972130
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nonantimicrobial effects of tetracyclines].
    García-Alvarez L; Oteo JA
    Rev Esp Quimioter; 2010 Mar; 23(1):4-11. PubMed ID: 20232018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.
    Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T
    Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tetracyclines on bone metabolism.
    Vernillo AT; Rifkin BR
    Adv Dent Res; 1998 Nov; 12(2):56-62. PubMed ID: 9972123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of chemically modified tetracyclines (CMTs) in experimental models of cancer and arthritis.
    Seftor EA; Seftor RE; Nieva DR; Hendrix MJ
    Adv Dent Res; 1998 Nov; 12(2):103-10. PubMed ID: 9972131
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of chemically modified tetracyclines (CMTs) on human keratinocyte proliferation and migration.
    Mäkelä M; Sorsa T; Uitto VJ; Salo T; Teronen O; Larjava H
    Adv Dent Res; 1998 Nov; 12(2):131-5. PubMed ID: 9972137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells.
    Hanemaaijer R; Visser H; Koolwijk P; Sorsa T; Salo T; Golub LM; van Hinsbergh VW
    Adv Dent Res; 1998 Nov; 12(2):114-8. PubMed ID: 9972133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New uses for tetracyclines.
    J Am Dent Assoc; 1997 Jul; 128(7):822, 826. PubMed ID: 9231598
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of bone resorption by tetracyclines.
    Rifkin BR; Vernillo AT; Golub LM; Ramamurthy NS
    Ann N Y Acad Sci; 1994 Sep; 732():165-80. PubMed ID: 7978789
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of matrix metalloproteinase-mediated periodontal bone loss in rats: a comparison of 6 chemically modified tetracyclines.
    Ramamurthy NS; Rifkin BR; Greenwald RA; Xu JW; Liu Y; Turner G; Golub LM; Vernillo AT
    J Periodontol; 2002 Jul; 73(7):726-34. PubMed ID: 12146531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury.
    Nieman GF; Zerler BR
    Curr Med Chem; 2001 Feb; 8(3):317-25. PubMed ID: 11172686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetracycline-based MMP inhibitors can prevent fibroblast-mediated collagen gel contraction in vitro.
    Myers SA; Wolowacz RG
    Adv Dent Res; 1998 Nov; 12(2):86-93. PubMed ID: 9972128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP inhibition by chemically modified tetracycline-3 (CMT-3) in equine pulmonary epithelial lining fluid.
    Maisi P; Kiili M; Raulo SM; Pirilä E; Sorsa T
    Ann N Y Acad Sci; 1999 Jun; 878():675-7. PubMed ID: 10415805
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Chemically Modified Tetracyclines in the Management of Periodontal Diseases: A Review.
    Ghangurde AA; Ganji KK; Bhongade ML; Sehdev B
    Drug Res (Stuttg); 2017 May; 67(5):258-265. PubMed ID: 28268238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of an inhibitor of matrix metalloproteinases on spontaneous osteoarthritis in guinea pigs.
    de Bri E; Lei W; Svensson O; Chowdhury M; Moak SA; Greenwald RA
    Adv Dent Res; 1998 Nov; 12(2):82-5. PubMed ID: 9972127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemically modified tetracyclines inhibit inducible nitric oxide synthase expression and nitric oxide production in cultured rat mesangial cells.
    Trachtman H; Futterweit S; Greenwald R; Moak S; Singhal P; Franki N; Amin AR
    Biochem Biophys Res Commun; 1996 Dec; 229(1):243-8. PubMed ID: 8954113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-antimicrobial properties of tetracyclines--dental and medical implications.
    Rawal SY; Rawal YB
    West Indian Med J; 2001 Jun; 50(2):105-8. PubMed ID: 11677904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of non-antibacterial tetracyclines. Part II.
    Golub LM; Greenwald RA
    Pharmacol Res; 2011 Dec; 64(6):549-50. PubMed ID: 21712090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.